About UICC

BOD 2014-2016

The Board of Directors, elected on 2nd December 2014 by the General Assembly in Melbourne, Australia will serve until November 2016.

Between assemblies, a board of 17 directors, elected by the General Assembly, act as the executive body of UICC.

The following individuals have been elected:

PRESIDENT  
 
Tezer Kutluk
(Turkey)
Biography
 
   
PRESIDENT-ELECT IMMEDIATE-PAST PRESIDENT
Sanchia Aranda
(Australia)
Biography 
Mary Gospodarowicz
(Canada)
Biography

 

BOARD MEMBERS

Benjamin O. Anderson (United States)

Benjamin O. Anderson, MD is a Professor of Surgery and Global Health-Medicine at the University of Washington School of Medicine in Seattle, Joint Member in Public Health Sciences at the Fred Hutchinson Cancer Research Center (FHCRC) and Director of the Breast Health Clinic at the Seattle Cancer Care Alliance (SCCA). Dr Anderson trained in surgical oncology as an American Cancer Society Clinical Oncology Fellow at the Memorial Sloan-Kettering Cancer Center in New York. Dr Anderson serves as Chair and Director of the Breast Health Global Initiative (BHGI) to address breast healthcare guideline development and implementation in low- and middle-income countries. 

Download Ben Anderson's full biography

Greg Bontrager (United States)

As the chief operating officer for the American Cancer Society, Greg Bontrager oversees operations for the world’s largest voluntary health organisation. He provides leadership and direction to all functions of the Society, including its expanding global endeavours. He also supervises the Society’s non-partisan 501(c) (4) advocacy affiliate, the American Cancer Society Cancer Action Network. Mr Bontrager has worked for ACS for over 20 years. Since becoming enterprise COO, he has represented the Society at numerous international events and his interest in expanding the Society’s global mission is well known. He presently oversees the Society’s initiative to develop an enterprise-wide global strategy. 

Heather Bryant (Canada) 

Dr Bryant is a public health physician and epidemiologist whose career has focused on population-based cancer control. In 1990, at the Alberta Cancer Board, she implemented the first population-based breast screening programme in the province. As Vice President of Population Health and Information, she led the cancer registry, population-based research, active screening and prevention programmes, and implementation of the patient electronic health record. In 2008, she joined the Canadian Partnership Against Cancer as Vice President Cancer Control, and is implementing the Canadian cancer control strategy with partners throughout the country. She has chaired many national committees in cancer control, screening, and research. 

Download Heather Bryant's full biography

Maira Caleffi (Brazil)

MD and PhD. Dr Caleffi is Head of the Breast Center at Hospital Moinhos de Vento and coordinator of Nucleo Mama Porto Alegre. She holds Pharmacy and Medicine degrees and a residency in Gynecology and Obstetrics. She completed her doctoral thesis at the University of London, and undertook postdoctoral studies in molecular biology in genetics and breast cancer at Vanderbilt University. Dr Caleffi is the founder and the Volunteer President of IMAMA and FEMAMA. She is a member of The Brazilian Association of Palliative Care; Brazilian Breast Cancer Study Group (GBECAM); ASCO; Breast Health Global Initiative (BHGI); The Harvard School of Public Health - GTF.CCC; ISPOR; Unión Latinoamericana Contra el Cáncer de la Mujer (ULACCAM).

Download Maira Caleffi's full biography

Anil D'Cruz (India)

Professor D’Cruz is Director of Tata Memorial Hospital, India’s largest comprehensive tertiary care hospital registering over 35000 new cases annually. In addition he is Professor and Chief, Department of Head and Neck Surgery, a key focus area as head and neck cancers are the commonest cancer in India accounting for approx 30% of cases. He is committed to the causes of prevention, early detection, service, education and research in the field of cancer. Professor D’Cruz has held leadership positions in numerous professional bodies nationally and internationally. He has over 125 peer reviewed publications and text book chapters and has been the lead investigator for numerous self initiated and global multicentre trials. His research is focussed on innovation, novel therapy and cost effective strategies.

Jeff Dunn (Australia)

With a PhD in sociology, I have over 20 years of experience in cancer control. I am the CEO of a Member Organisation with a long history of supporting the UICC. I have served the UICC since 1991, as a Strategic Leader and Capacity Building Fund Chairperson. I am currently a Member of the World Leaders’ Forum. I bring strong links to international cancer programs as President of the Asian Pacific Organisation for Cancer Prevention, Chair of the Asia Pacific Cancer Society Training Grant Program, Chair of Reach to Recovery International and Secretary of the International Psycho-Oncology Society. 

 

Serigne Gueye (Senegal)

Dr Serigne Gueye is Professor and Chair of Urology at the Grand Yoff General Hospital and University Cheikh Anta DIOP, Dakar, Senegal. He is former Fulbright scholar at University of Pennsylvania, USA. He is President of ALIAM (Alliance of African and Mediterranean Leagues against cancer) and the Senegalese Society of Cancer (SOSECAN). He is Past President of AORTIC. He received in 2011 the AACR Landon Award for excellence in international collaboration on cancer research. Field surgeon during the Rwandese genocide (1994), Dr Gueye was recipient of United Nations’ Medal for Peace and many other medals in Senegal, Chad and France. 

Xishan Hao (China)

Dr Xishan Hao is a leading surgical oncologist, medical educator and an active member of NGOs. During his forty years in practice, he has earned numerous awards for his innovative approach in surgery and contribution to the advancement of public health and medical education.  He was elected as an academician of the Chinese Academy of Engineering, the highest honor in the field of science in China. He committed himself to cancer control not only in Asia but also globally. He serves as the President of Chinese Anti-Cancer Association, Executive Council Member of APFOCC and Board of Director of UICC (2006 -2012).

 

Jamal Khader (Jordan)

Dr Jamal Khader is a consultant Radiation oncologist at King Hussein Cancer Center in Amman, Jordan. He is Director of the International Affairs Center and the Director of the Radiation oncology Residency programme, Head of the Lung Cancer Service, and serves on several institutional committees such as the Graduate Medical Education Committee. Dr Khader is a member of local, regional and international committees and associations. He is the Chairman of the scientific committee of the Jordanian Oncology Society, and member of the editorial board of the Pan Arab Oncology journal as well as a member in the Jordanian Chapter of the Mediterranean Task Force for Cancer Control. 

Download Download Jamal Khader's full biography

Harpal Kumar (United Kingdom)

I studied Chemical Engineering at Cambridge University and gained an MBA from Harvard Business School. After working as a research scientist with the UK Atomic Energy Authority, I joined McKinsey, advising pharmaceutical clients and health care organisations. I then became CEO of The Papworth Trust, providing pioneering rehabilitation services for people with acquired disabilities. In 1997 I became CEO of Nexan, a medical device company creating novel cardio-respiratory monitoring technologies. I joined Cancer Research UK in 2002, becoming COO in 2004 and CEO in 2007. I chair the UK’s National Cancer Research Institute and the National Awareness and Early Diagnosis Initiative.

Gilbert Lenoir (France)

Gilbert Lenoir is Professor of Medical genetics. He is a Board Member (since 1998) and past President (2010-2012) of the “Ligue Française contre le Cancer” (the major French Cancer charity). He has dedicated his entire career to cancer. A scientist at the Interna- tional Agency for Research on Cancer (IARC – Lyon, France), and professor at the medical school, he was appointed as Deputy Director in charge of research at the Institut Gustave Roussy, Villejuif in 2000. Since 2010 he has been in charge of the Paris biocluster programme: Cancer Campus. He is the author of more than 400 articles in cancer genetics, epidemiological and translational research.

Tetsuo Noda (Japan)

Tetsuo Noda, MD, PhD is the Representative Director of Japanese Foundation for Cancer Research (JFCR), the largest foundation for cancer research and treatment in Japan. He also serves as a president of the Japanese Cancer Association (JCA), the largest association of cancer researchers in Japan. He graduated from Tohoku University School of Medicine in 1980 and obtained a PhD on the study of tumor immunology in 1984. After postdoctoral training in the US (NCI and MIT), he became a professor of molecular genetics of Tohoku University School of Medicine in 1998. He has been a member of fellowship committee of UICC since 2007.

 

Anne-Lise Ryel (Norway)

Anne Lise Ryel was born in Tromsø, Norway, in 1958. She obtained a Law Degree at the University of Oslo in 1987. She worked as Junior Lawyer at Hjort DA from 1988 and then as Lawyer at a Hydro-power Grid Company, Statnett SF, from 1992 to 1994 until her appointment as the Norwegian Gender Equality Ombudsman. She served as State Secretary at the Ministry of Justice in the Stoltenberg First Government in 2001 and as Deputy Director General at the Norwegian Directorate of Health in 2002. Ms. Ryel has been Secretary General of the Norwegian Cancer Society since 2002. 

 

Richard Sullivan (United Kingdom)

I was raised in the Middle East and East Africa before coming back the UK where I studied medicine at St. Marys Hospital, Paddington. After training in academic uro-oncology surgery, I joined Cancer Research UK as clinical director. After CRUK I led the emerging countries health, population and society theme at London School of Economics before joining Kings Health Partners as Chair, Cancer Policy and Global Health. At KHP I direct the Institute of Cancer Policy which focuses on global cancer health, and the Kings Conflict & Health program, particularly around NCD control in fragile countries.